Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Sandheeah Ramdeny, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, Ajay Vora

Blood Adv (2021) 5 (8): 2153–2155.

https://doi.org/10.1182/bloodadvances.2021004284

Published: 2021

Journal Articles

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Adv (2020) 4 (16): 3913–3925.

https://doi.org/10.1182/bloodadvances.2020001648

Published: 2020

Includes: Supplemental data

Journal Articles

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Amy E. DeZern, Marianna L. Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky

Blood Adv (2020) 4 (8): 1770–1779.

https://doi.org/10.1182/bloodadvances.2020001729

Published: 2020

Includes: Supplemental data

Journal Articles

Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation

Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura

Blood Adv (2020) 4 (4): 667–671.

https://doi.org/10.1182/bloodadvances.2019000343

Published: 2020

Includes: Supplemental data

Journal Articles

Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice

Katherine C. Wood, Brittany G. Durgin, Heidi M. Schmidt, Scott A. Hahn, Jeffrey J. Baust, Tim Bachman, Dario A. Vitturi, Samit Ghosh, Solomon F. Ofori-Acquah, Ana L. Mora, Mark T. Gladwin, Adam C. Straub

Blood Adv (2019) 3 (23): 4104–4116.

https://doi.org/10.1182/bloodadvances.2019000621

Published: 2019

Includes: Supplemental data

Journal Articles

Building blocks of hematology in the last 3 decades in Pakistan

Blood Adv (2019) 3 (Supplement 1): 27–30.

https://doi.org/10.1182/bloodadvances.2019GS121580

Published: 2019

Journal Articles

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

Blood Adv (2019) 3 (20): 3123–3131.

https://doi.org/10.1182/bloodadvances.2019000722

Published: 2019

Includes: Supplemental data

Journal Articles

Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

Philip H. Imus, Hua-Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan M. Borrello, Lode J. Swinnen, Nina Wagner-Johnston, Christian B. Gocke, Syed Abbas Ali, F. Javier Bolaños-Meade, Ravi Varadhan, Richard J. Jones

Blood Adv (2019) 3 (17): 2608–2616.

https://doi.org/10.1182/bloodadvances.2019000155

Published: 2019

Includes: Supplemental data

Journal Articles

External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation

Roni Shouval, Joshua A. Fein, Aniela Shouval, Ivetta Danylesko, Noga Shem-Tov, Maya Zlotnik, Ronit Yerushalmi, Avichai Shimoni, Arnon Nagler

Blood Adv (2019) 3 (12): 1881–1890.

https://doi.org/10.1182/bloodadvances.2019032268

Published: 2019

Includes: Supplemental data

Journal Articles

Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1

Hairui Su, Chiao-Wang Sun, Szu-Mam Liu, Xin He, Hao Hu, Kevin M. Pawlik, Tim M. Townes, Xiaosi Han, Christopher A. Klug, Maged Henary, Yabing Chen, Ling Li, Y. George Zheng, Xinyang Zhao

Blood Adv (2018) 2 (21): 2829–2836.

https://doi.org/10.1182/bloodadvances.2018020727

Published: 2018

Includes: Supplemental data

Journal Articles

Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Laura K. Schoch, Kenneth R. Cooke, Nina D. Wagner-Johnston, Ivana Gojo, Lode J. Swinnen, Philip Imus, Ephraim J. Fuchs, Mark Levis, Richard F. Ambinder, Richard J. Jones, Douglas E. Gladstone

Blood Adv (2018) 2 (17): 2226–2229.

https://doi.org/10.1182/bloodadvances.2018019208

Published: 2018

Journal Articles

Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment

George E. Georges, Kris Doney, Rainer Storb

Blood Adv (2018) 2 (15): 2020–2028.

https://doi.org/10.1182/bloodadvances.2018021162

Published: 2018

Journal Articles

Richardson PG, Carreras E, Iacobelli M, Nejadnik B. The use of defibrotide in blood and marrow transplantation. Blood Adv. 2018;2(12):1495-1509.

Blood Adv (2018) 2 (15): 1853.

https://doi.org/10.1182/bloodadvances.2018023168

Published: 2018

Journal Articles

Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models

Paola Rivera-Munoz, Anouchka P. Laurent, Aurelie Siret, Cecile K. Lopez, Cathy Ignacimouttou, Melanie G. Cornejo, Olivia Bawa, Philippe Rameau, Olivier A. Bernard, Philippe Dessen, Gary D. Gilliland, Thomas Mercher, Sébastien Malinge

Blood Adv (2018) 2 (13): 1616–1627.

https://doi.org/10.1182/bloodadvances.2018016089

Published: 2018

Includes: Supplemental data

Journal Articles

The use of defibrotide in blood and marrow transplantation

Paul G. Richardson, Enric Carreras, Massimo Iacobelli, Bijan Nejadnik

Blood Adv (2018) 2 (12): 1495–1509.

https://doi.org/10.1182/bloodadvances.2017008375

Published: 2018

Journal Articles

Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation

Coco de Koning, Julie-Anne Gabelich, Jurgen Langenhorst, Rick Admiraal, Jurgen Kuball, Jaap Jan Boelens, Stefan Nierkens

Blood Adv (2018) 2 (5): 565–574.

https://doi.org/10.1182/bloodadvances.2017015487

Published: 2018

Includes: Supplemental data

Journal Articles

Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies

Blood Adv (2018) 2 (1): 49–60.

https://doi.org/10.1182/bloodadvances.2017010645

Published: 2018

Includes: Supplemental data

Journal Articles

ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia

Blood Adv (2017) 1 (13): 792–801.

https://doi.org/10.1182/bloodadvances.2016004119

Published: 2017

Journal Articles

Bone marrow transplantation prevents right ventricle disease in the caveolin-1 –deficient mouse model of pulmonary hypertension

Kewal Asosingh, Nicholas Wanner, Kelly Weiss, Kimberly Queisser, Liya Gebreab, Biruk Kassa, Eric Stuehr, Brian Graham, Serpil Erzurum

Blood Adv (2017) 1 (9): 526–534.

https://doi.org/10.1182/bloodadvances.2016002691

Published: 2017

Journal Articles

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik

Blood Adv (2017) 1 (4): 288–292.

https://doi.org/10.1182/bloodadvances.2016002766

Published: 2017

Includes: Supplemental data

NARROW

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation

Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice

Building blocks of hematology in the last 3 decades in Pakistan

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation

Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1

Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment

Richardson PG, Carreras E, Iacobelli M, Nejadnik B. The use of defibrotide in blood and marrow transplantation. Blood Adv. 2018;2(12):1495-1509.

Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models

The use of defibrotide in blood and marrow transplantation

Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation

Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies

ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia

Bone marrow transplantation prevents right ventricle disease in the caveolin-1 –deficient mouse model of pulmonary hypertension

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only